Pharma News

Ibuprofen could add years in your life

  • Posted on: 22 December 2014
  • By: PharmaTutor News

Ibuprofen, a common over-the-counter drug used to relieve pain and fever, could hold the keys to a longer healthier life, according to a study by researchers at the Buck Institute for Research on Aging. Publishing in PLoS Genetics on December 18th, scientists showed that regular doses of ibuprofen extended the lifespan of yeast, worms and fruit flies.

Action taken by CDSCO against misuse and unethical stem cell clinical trial malpractices at hospital

  • Posted on: 16 December 2014
  • By: PharmaTutor News

Central Drugs Standard Control Organization (CDSCO) investigated a Pune based hospital after receiving compliant against hospital that they are performing unethical stem cell clinical trial and patients are highly charged for unapproved and illegal transplants.

Ministry of Health and Family Welfare strengthening Drug Regulatory System in India

  • Posted on: 12 December 2014
  • By: PharmaTutor News

Department of Health and Family Welfare proposes to implement a Central Sector Scheme for Strengthening the Central Drugs Standard Control Organisation (CDSCO); and State Drug Regulatory System during the residual period of Twelfth Five Year Plan (2012 - 2017) at an estimated cost of Rs.900 crore and Rs.850 crore (excluding States’ share) respectively.

Tata Capital’s ‘India4India’ Survey Identifies Basic Healthcare and Illiteracy as the Top Challenges That India is Facing

  • Posted on: 11 December 2014
  • By: PharmaTutor News

(Business Wire India); Tata Capital, the financial services arm of the Tata Group, as part of its Do Right initiative, concluded a first-of-its-kind Survey to identify the major challenges facing our country today. The “Tata Capital India4India” Survey was conducted online on the website – doright.in & saw voting from more than 5000 respondents across the country. The top five challenges that emerged as the most concerning for the Indian public were Basic Healthcare, Illiteracy, Child Rights, Women Empowerment and Food Scarcity.

Naloxegol from Astrazeneca approved by EU

  • Posted on: 10 December 2014
  • By: PharmaTutor News

AstraZeneca announced that MOVENTIG® (naloxegol) has been granted Marketing Authorisation by the European Commission (EC) for the treatment of opioid-induced constipation (OIC) in adult patients who have had an inadequate response to laxative(s). MOVENTIG is the first once-daily oral peripherally-acting mu-opioid receptor antagonist (PAMORA) to be approved in the European Union (EU).

Scientists found molecules that convert White fat to Brown / Good Fat

  • Posted on: 10 December 2014
  • By: PharmaTutor News

Harvard Stem Cell Institute (HSCI) researchers have taken what they describe as “the first step toward a pill that can replace the treadmill” for the control of obesity, though that shift, of course, would not provide all of the many benefits of exercise.

3D vaccines injection could fight cancer and HIV

  • Posted on: 10 December 2014
  • By: PharmaTutor News

One of the reasons cancer is so deadly is that it can evade attack from the body's immune system, which allows tumors to flourish and spread. Scientists can try to induce the immune system, known as immunotherapy, to go into attack mode to fight cancer and to build long lasting immune resistance to cancer cells. Now, researchers at the Wyss Institute for Biologically Inspired Engineering at Harvard University and Harvard's School of Engineering and Applied Sciences (SEAS) show a non-surgical injection of programmable biomaterial that spontaneously assembles in vivo into a 3D structure could fight and even help prevent cancer and also infectious disease such as HIV. Their findings are reported in Nature Biotechnology.

Pages